vs
Acadia Healthcare Company, Inc.（ACHC）与JBT Marel Corp（JBTM）财务数据对比。点击上方公司名可切换其他公司
JBT Marel Corp的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$1.0B vs $829.0M），JBT Marel Corp净利率更高（5.3% vs 0.5%，领先4.7%），JBT Marel Corp同比增速更快（115.6% vs 7.5%），过去两年JBT Marel Corp的营收复合增速更高（60.3% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
JBT Marel Corp（原称JBT公司、约翰宾技术公司）是主营食品加工机械及自动化车辆的企业，2008年由FMC技术公司拆分非能源业务独立注册成立，总部位于美国伊利诺伊州芝加哥，发展历史可追溯至1884年加州洛斯加托斯果园主约翰·宾创办的企业。
ACHC vs JBTM — 直观对比
营收规模更大
JBTM
是对方的1.2倍
$829.0M
营收增速更快
JBTM
高出108.0%
7.5%
净利率更高
JBTM
高出4.7%
0.5%
两年增速更快
JBTM
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.0B |
| 净利润 | $4.5M | $53.1M |
| 毛利率 | — | 34.5% |
| 营业利润率 | — | 7.2% |
| 净利率 | 0.5% | 5.3% |
| 营收同比 | 7.5% | 115.6% |
| 净利润同比 | -50.8% | 858.6% |
| 每股收益（稀释后） | $0.05 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCJBTM
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $934.8M | ||
| Q1 25 | $770.5M | $854.1M | ||
| Q4 24 | $774.2M | $467.6M | ||
| Q3 24 | $815.6M | $453.8M | ||
| Q2 24 | $796.0M | $402.3M |
净利润ACHCJBTM
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $53.1M | ||
| Q3 25 | $36.2M | $66.0M | ||
| Q2 25 | $30.1M | $3.4M | ||
| Q1 25 | $8.4M | $-173.0M | ||
| Q4 24 | $32.6M | $-7.0M | ||
| Q3 24 | $68.1M | $38.9M | ||
| Q2 24 | $78.5M | $30.7M |
毛利率ACHCJBTM
| Q1 26 | — | — | ||
| Q4 25 | — | 34.5% | ||
| Q3 25 | — | 35.9% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 34.2% | ||
| Q4 24 | — | 38.4% | ||
| Q3 24 | — | 36.1% | ||
| Q2 24 | — | 35.6% |
营业利润率ACHCJBTM
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 7.2% | ||
| Q3 25 | 4.7% | 10.2% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | -3.9% | ||
| Q4 24 | 4.9% | 3.4% | ||
| Q3 24 | 12.1% | 10.3% | ||
| Q2 24 | 13.4% | 6.7% |
净利率ACHCJBTM
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 5.3% | ||
| Q3 25 | 4.3% | 6.6% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 1.1% | -20.3% | ||
| Q4 24 | 4.2% | -1.5% | ||
| Q3 24 | 8.4% | 8.6% | ||
| Q2 24 | 9.9% | 7.6% |
每股收益（稀释后）ACHCJBTM
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.04 | ||
| Q3 25 | $0.40 | $1.26 | ||
| Q2 25 | $0.33 | $0.07 | ||
| Q1 25 | $0.09 | $-3.35 | ||
| Q4 24 | $0.36 | $-0.22 | ||
| Q3 24 | $0.74 | $1.21 | ||
| Q2 24 | $0.85 | $0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $167.9M |
| 总债务越低越好 | $2.5B | $1.5B |
| 股东权益账面价值 | $2.0B | $4.5B |
| 总资产 | $5.5B | $8.2B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.33× |
8季度趋势，按日历期对齐
现金及短期投资ACHCJBTM
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $167.9M | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | $1.2B | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
总债务ACHCJBTM
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.0B | $1.3B | ||
| Q3 24 | $1.9B | $648.3M | ||
| Q2 24 | $1.8B | $647.7M |
股东权益ACHCJBTM
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $4.5B | ||
| Q3 25 | $3.1B | $4.4B | ||
| Q2 25 | $3.1B | $4.4B | ||
| Q1 25 | $3.0B | $4.1B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.6B | ||
| Q2 24 | $3.0B | $1.5B |
总资产ACHCJBTM
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $8.2B | ||
| Q3 25 | $6.4B | $8.2B | ||
| Q2 25 | $6.3B | $8.3B | ||
| Q1 25 | $6.1B | $8.0B | ||
| Q4 24 | $6.0B | $3.4B | ||
| Q3 24 | $5.9B | $2.8B | ||
| Q2 24 | $5.7B | $2.7B |
负债/权益比ACHCJBTM
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.33× | ||
| Q3 25 | 0.74× | 0.34× | ||
| Q2 25 | 0.74× | 0.35× | ||
| Q1 25 | 0.72× | 0.48× | ||
| Q4 24 | 0.64× | 0.81× | ||
| Q3 24 | 0.62× | 0.41× | ||
| Q2 24 | 0.62× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $117.4M |
| 自由现金流经营现金流 - 资本支出 | — | $83.5M |
| 自由现金流率自由现金流/营收 | — | 8.3% |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | 13.78× | 2.21× |
| 过去12个月自由现金流最近4个季度 | — | $238.1M |
8季度趋势，按日历期对齐
经营现金流ACHCJBTM
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $117.4M | ||
| Q3 25 | $73.2M | $87.7M | ||
| Q2 25 | $133.5M | $102.2M | ||
| Q1 25 | $11.5M | $34.4M | ||
| Q4 24 | $116.7M | $128.7M | ||
| Q3 24 | $163.1M | $71.9M | ||
| Q2 24 | $171.1M | $21.6M |
自由现金流ACHCJBTM
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $83.5M | ||
| Q3 25 | $-63.0M | $56.5M | ||
| Q2 25 | $-34.2M | $83.7M | ||
| Q1 25 | $-163.2M | $14.4M | ||
| Q4 24 | $-86.8M | $118.7M | ||
| Q3 24 | $-27.1M | $65.0M | ||
| Q2 24 | $16.9M | $11.1M |
自由现金流率ACHCJBTM
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 8.3% | ||
| Q3 25 | -7.4% | 5.6% | ||
| Q2 25 | -3.9% | 9.0% | ||
| Q1 25 | -21.2% | 1.7% | ||
| Q4 24 | -11.2% | 25.4% | ||
| Q3 24 | -3.3% | 14.3% | ||
| Q2 24 | 2.1% | 2.8% |
资本支出强度ACHCJBTM
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.4% | ||
| Q3 25 | 16.0% | 3.1% | ||
| Q2 25 | 19.3% | 2.0% | ||
| Q1 25 | 22.7% | 2.3% | ||
| Q4 24 | 26.3% | 2.1% | ||
| Q3 24 | 23.3% | 1.5% | ||
| Q2 24 | 19.4% | 2.6% |
现金转化率ACHCJBTM
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.21× | ||
| Q3 25 | 2.02× | 1.33× | ||
| Q2 25 | 4.43× | 30.06× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 1.85× | ||
| Q2 24 | 2.18× | 0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
JBTM
暂无分部数据
